Dr. Lisa M. Davis co-authors 'Anti-Inflammatory Foods for Health' to be
released January 1, 2008
OWINGS MILLS, Md., Dec. 26 /PRNewswire-FirstCall/ -- Medifast, Inc. (NYSE: MED) today announced that Director of Research & Development, Lisa M. Davis, Ph.D., PA-C, C.N.S., L.D.N., has co-authored a book investigating ways to incorporate Omega-3-rich foods into the diet to fight arthritis, cancer, heart disease and other health issues. "Anti-Inflammatory Foods for Health" is co-authored by Barbara Rowe, M.P.H., R.D., L.D., C.N.S.D., and is scheduled for release on January 1, 2008.
"One of the best ways to achieve optimal health is to incorporate more Omega-3s into your diet," says Davis. "'Anti-Inflammatory Foods for Health' will be a great resource for Americans to learn more about anti-inflammatory foods and how they can easily add more Omega-3s to their diets, and at Medifast we'll be incorporating Omega-3's into our program with new products and programs for our customers in early 2008"
Swelling, redness and heat are the body's acute inflammatory responses to trauma, and an essential part of the healing process. Inflammation can be harmful when it lasts too long and the body reacts as though under attack. Researchers are now linking low-grade, persistent inflammation to premature aging, heart disease, MS, diabetes, Alzheimer's, psoriasis, arthritis and cancer.
Some types of inflammation can be remedied by a change in diet, specifically by altering the types of fats consumed. Omega-3 fatty acids tend to decrease inflammation, while Omega-6 fatty acids increase inflammation. While many foods in the standard American diet exacerbate inflammation, a healthy diet made up of fish, nuts, seeds, oils, lean grass-fed meats, fruits and vegetables can help lessen or prevent inflammation.
"Anti-Inflammatory Foods for Health" will help those with inflammation incorporate anti-inflammatory foods into their everyday diets. Sample recipes include French-Canadian pea soup, sumac salmon, maple-ginger butternut squash, lime-ginger glazed chicken with fennel relish, green salad with grapes and sunflower seeds and cod with saffron sauce.
Davis was previously a researcher at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Md., and a clinician at the Johns Hopkins Weight Management Center. She has been quoted frequently in the popular press regarding inflammation and diet. Her research involves examining the relationship between brain neurotransmitters and markers of inflammation.
Rowe has more than sixteen years of experience as a dietician and was a program manager at John Hopkins Weight Management Center. She has worked individually with countless clients to help them manage their health through diet and has authored several articles on nutrition and inflammation. Rowe uses her vast knowledge of nutrition to develop tasty recipes that promote good health.
"Anti-Inflammatory Foods for Health" is being published by Fair Winds Press, an imprint of Quayside Publishing Group, publishers of cook books, health and body books, self-help books, lifestyle books, spirituality books and free masonry books.
Medifast (NYSE: MED) is the leading easy-to-use, clinically proven portion-controlled weight loss program. Medifast has been recommended by 15,000 physicians and used by over one million customers. It is committed to enriching lives by providing innovative choices for lasting health. Medifast programs have been proven effective through studies by major university teaching hospitals. The company sells its products and programs via four unique distribution channels: 1) the web and national call centers, 2) national network of physicians, 3) medically supervised Medifast Weight Control Centers and 4) the Take Shape For Life direct-selling division, a network of health coaches. Medifast was founded in 1980 and is located in Owings Mills, Maryland. For more information, log onto http://www.ChooseMedifast.com.
Please Note: This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as "intend" or other similar words or the negative of such terminology. Similarly, descriptions of Medifast's objectives, strategies, plans, goals or targets contained herein are also considered forward-looking statements. Medifast believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, Medifast's inability to attract and retain independent Associates and Members, stability in the pricing of print, TV and Direct Mail marketing initiatives affecting the cost to acquire customers, increases in competition, litigation, regulatory changes, and its planned growth into new domestic and international markets and new channels of distribution. Although Medifast's believes that the expectations, statements, and assumptions reflected in these forward- looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K and Quarterly Report on Form 10-Q, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
|SOURCE Medifast, Inc.|
Copyright©2007 PR Newswire.
All rights reserved